Inhaled corticosteroids in COPD: friend or foe?

Alvar Agusti, Leonardo M. Fabbri, Dave Singh, Jorgen Vestbo, Bartolome Celli, Frits M. E. Franssen, Klaus F. Rabe, Alberto Papi

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Article number1801219
Number of pages14
JournalEuropean Respiratory Journal
Volume52
Issue number6
DOIs
Publication statusPublished - 1 Dec 2018

Keywords

  • OBSTRUCTIVE PULMONARY-DISEASE
  • FLUTICASONE PROPIONATE/SALMETEROL 250/50
  • COMMUNITY-ACQUIRED PNEUMONIA
  • BLOOD EOSINOPHIL COUNT
  • AIR-FLOW LIMITATION
  • POST-HOC ANALYSIS
  • DOUBLE-BLIND
  • LUNG-FUNCTION
  • TRIPLE THERAPY
  • PARALLEL-GROUP

Cite this

Agusti, A., Fabbri, L. M., Singh, D., Vestbo, J., Celli, B., Franssen, F. M. E., Rabe, K. F., & Papi, A. (2018). Inhaled corticosteroids in COPD: friend or foe? European Respiratory Journal, 52(6), [1801219]. https://doi.org/10.1183/13993003.01219-2018